SIRT2 inhibition protects against cardiac hypertrophy and ischemic injury is a research paper published in eLife (2023). On theSindex it has a DataRank of 0.988. It has been cited 24 times, with 24 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.483
From this paper's citation signal
Citation Network Contribution
0.505
From 21 citing papers with measurable signal
American Heart Association
Grant: 14POST20490097
National Institutes of Health
Grant: R01 HL138982
American Heart Association
Grant: POST000204352
National Institutes of Health
Grant: R01 HL140927
Leducq
Grant: Cardiooncology Network
NHLBI NIH HHS
Grant: R01 HL155953
National Institutes of Health
Grant: R01 HL140973
National Institutes of Health
Grant: 1R01HL140973-01
Mechanistic insights into HIV-mediated heart failure with preserved ejection fraction
National Institutes of Health
Grant: 5R01HL138982-03
Mechanistic insights into the deleterious effects of SIRT2 in the heart under stress conditions
National Institutes of Health
Grant: 1R01HL155953-01A1
Role of mRNA-binding protein tristetraprolin in cardiac mRNA regulation and the development of heart failure
National Institutes of Health
Grant: 5R01HL140927-02
Mechanistic insights into the role of mitochondrial iron in doxorubicin-induced cardiomyopathy using human induced pluripotent stem cells
FWCI
3.89
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals